Annals of Oncology Advance Access published online on August 5, 2005
Annals of Oncology, doi:10.1093/annonc/mdi363
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Unité d'Epidémiologie du Cancer, Institut Universitaire de Médecine Sociale et Préventive, Bugnon 17, 1005 Lausanne; Registre Vaudois des Tumeurs, Institut Universitaire de Médecine Sociale et Préventive, CHUV-Falaises 1, 1011 Lausanne; Registre Neuchâtelois des Tumeurs, avenue de Cadolles 7, 2000 Neuchâtel, Switzerland
* To whom correspondence should be addressed.
Background: Adjuvant radiation therapy for breast cancer has been related to excess esophageal cancer risk, but population-based data are scanty. Patients and methods: We considered esophageal cancer risk among 11 130 breast cancer patients diagnosed between 1974 and 2002 in the Swiss cantons of Vaud and Neuchâtel, and followed-up to the end of 2002, for a total of 75 900 women-years at risk. Results: Overall, 18 cases were observed compared with 8.9 expected, corresponding to a standardised incidence ratio (SIR) of 2.0 [95% confidence interval (CI) 1.2-3.2]. The SIR was 1.6 in the first 10 years after diagnosis and 3.3 for Conclusions: These data confirm an excess esophageal cancer risk following treatment for breast cancer which could not be explained by confounding of tobacco or alcohol alone. The excess risk tended to decrease for cases diagnosed after 1988, leaving open the issue of the risk of modern radiotherapy for breast cancer on esophageal cancer.
Received April 22, 2005
Revised June 14, 2005
Accepted June 22, 2005
Original article
Increased risk of esophageal cancer after breast cancer
2 Unité d'Epidémiologie du Cancer, Institut Universitaire de Médecine Sociale et Préventive, Bugnon 17, 1005 Lausanne; Registre Vaudois des Tumeurs, Institut Universitaire de Médecine Sociale et Préventive, CHUV-Falaises 1, 1011 Lausanne
3 Registre Vaudois des Tumeurs, Institut Universitaire de Médecine Sociale et Préventive, CHUV-Falaises 1, 1011 Lausanne
4 Unité d'Epidémiologie du Cancer, Institut Universitaire de Médecine Sociale et Préventive, Bugnon 17, 1005 Lausanne; Istituto di Biometria e Statistica Medica, Università degli Studi di Milano, via Venezian 1, 20133 Milan; Istituto di Ricerche Farmacologiche ‘Mario Negri’, via Eritrea 62, 20157 Milan, Italy
F. Levi, E-mail: fabio.levi{at}chuv.ch
![]()
Abstract
10 years after diagnosis, 2.3 for cases diagnosed between 1974 and 1988 and 1.5 for those diagnosed after 1988, 2.3 (based on 15 cases) for squamous cell cancer and 1.3 (based on three cases) for adenocarcinomas, and 2.9 for the upper third, 2.3 for the middle third and 1.9 for the lower third of the esophagus.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K.-D. Lee, S.-C. Chen, C. H. Chan, C.-H. Lu, C.-C. Chen, J.-T. Lin, M.-F. Chen, S.-H. Huang, C.-M. Yeh, and M.-C. Chen Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2647 - 2655. [Abstract] [Full Text] [PDF] |
||||
